Transave

Acquired by Insmed Inc.
Developing inhaled therapies for respiratory and lung infections.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Monmouth Junction, NJ

Initial Investment

2006
Developing inhaled therapies for respiratory and lung infections.

Transave is focused on improving the treatment of serious lung diseases through the company’s next generation, proprietary liposomal delivery technology. Transave was acquired by Insmed Inc.